Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets

Journal of Endocrinology

Volumn 214, Issue 3, 2012, Pages 301-311

  Krause, Mauricio da Silva ^a,b   Bittencourt, Aline ^c   de Bittencourt, Paulo Ivo Homem ^c   McClenaghan, Neville H ^d   Flatt, Peter R ^d   Murphy, Colin ^a   Newsholme, Philip ^b,e  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d UNIVERSITY OF ULSTER   (United Kingdom)

^e CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; NITRITE; UREA;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE INTAKE; GLUCOSE METABOLISM; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84866278132     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0223     Document Type: Article

References (41)

1. Alquier T, Kawashima J, Tsuji Y & Kahn BB. 2007 Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 148 1367-1375.
2. Brennan L, Shine A, Hewage C, Malthouse JP, Brindle KM, McClenaghan N, Flatt PR & Newsholme P. 2002 A nuclear magnetic resonance-based demonstration of substantial oxidative L-alanine metabolism and L-alanineenhanced glucose metabolism in a clonal pancreatic β-cell line: metabolism of L-alanine is important to the regulation of insulin secretion. Diabetes 51 1714-1721.
3. 13C NMR analysis reveals a link between L-glutamine metabolism and D-glucose metabolism and gamma-glutamyl cycle activity in a clonal pancreatic β-cell line. Diabetologia 46 1512-1521.
4. Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK & Febbraio MA. 2006a Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49 1000-1007.
5. Carey AL, Steinberg GR, Macaulay SL, ThomasWG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE et al. 2006b Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55 2688-2697.
6. Choi SE, Choi KM, Yoon IH, Shin JY, Kim JS, Park WY, Han DJ, Kim SC, Ahn C, Kim JY et al. 2004 IL-6 protects pancreatic islet b cells from proinflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transplant Immunology 13 43-53.
7. Dufer M, Noack K, Krippeit-Drews P & Drews G. 2010 Activation of the AMP-activated protein kinase enhances glucose-stimulated insulin secretion in mouse β-cells. Islets 2 156-163.
8. Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, Kerr-Conte J, Pattou F, Berney T, Pipeleers D et al. 2008 Interleukin-6 regulates pancreatic a-cell mass expansion. PNAS 105 13163-13168.
9. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD et al. 2011 Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and a cells. Nature Medicine 17 1481-1489.
10. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI & Sherman MY. 1997 Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. Journal of Biological Chemistry 272 18033-18037.
11. Gutierrez LL, Maslinkiewicz A, Curi R & de Bittencourt PI Jr. 2008 Atherosclerosis: a redox-sensitive lipid imbalance suppressible by cyclopentenone prostaglandins. Biochemical Pharmacology 75 2245-2262.
12. Herder C, Haastert B, Muller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S & Kolb H. 2005 Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54 (Suppl 2) S11-S17.
13. Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ & Lai LP. 2008 Metformin inhibits TNF-a-induced IkB kinase phosphorylation, IkΒ-a degradation and IL-6 production in endothelial cells through PI3Kdependent AMPK phosphorylation. International Journal of Cardiology 134 169-175.
14. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY, Shin HJ, Kim WS & Kim JB. 2009 Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology. Endocrinology and Metabolism 296 E955-E964.
15. Jobgen WS, Fried SK, Fu WJ, Meininger CJ & Wu G. 2006 Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. Journal of Nutritional Biochemistry 17 571-588.
16. Kamimura D, Ishihara K & Hirano T. 2003 IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of Physiology, Biochemistry and Pharmacology 149 1-38.
17. Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK et al. 2004 AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochemical and Biophysical Research Communications 320 449-454.
18. Kiely A, McClenaghan NH, Flatt PR & Newsholme P. 2007 Proinflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic β-cell line. Journal of Endocrinology 195 113-123.
19. Krause Mda S & de Bittencourt PI Jr. 2008 Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis Cell Biochemistry and Function 26 406-433.
20. Krause MS, Oliveira LP Jr, Silveira EM, Vianna DR, Rossato JS, Almeida BS, Rodrigues MF, Fernandes AJ, Costa JA, Curi R et al. 2007 MRP1/GS-X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress-induced redox imbalance in comparison to skeletal muscle cells? Cell Biochemistry and Function 25 23-32.
21. Krause MS, McClenaghan NH, Flatt PR, de Bittencourt PI, Murphy C & Newsholme P. 2011 L-arginine is essential for pancreatic β-cell functional integrity, metabolism and defense from inflammatory challenge. Journal of Endocrinology 211 87-97.
22. Lira VA, Soltow QA, Long JH, Betters JL, Sellman JE & Criswell DS. 2007 Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism 293 E1062-E1068.
23. McClenaghan NH & Flatt PR. 1999 Engineering cultured insulinsecreting pancreatic Β-cell lines. Journal of Molecular Medicine 77 235-243.
24. McClenaghan NH, Barnett CR, Ah-Sing E, Abdel-Wahab YH, O'Harte FP, Yoon TW, Swanston-Flatt SK & Flatt PR. 1996 Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45 1132-1140.
25. Murphy C & Newsholme P. 1996 Evidence for murine macrophage nitric oxide synthesis in the absence of exogenous L-arginine. Biochemical Society Transactions 24 463S.
26. Newsholme P, Keane D, Welters HJ & Morgan NG. 2007 Life and death decisions of the pancreatic β-cell: the role of fatty acids. Clinical Science 112 27-42.
27. Newsholme P,Homem De Bittencourt PI, O'Hagan C, De VitoG, MurphyC & Krause MS. 2009 Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide. Clinical Science 118 341-349.
28. Ostrowski K, Rohde T, Zacho M, Asp S & Pedersen BK. 1998 Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. Journal of Physiology 508 949-953.
29. Palmer JP, Benson JW, Walter RM & Ensinck JW. 1976 Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. Journal of Clinical Investigation 58 565-570.
30. Rodrigues-Krause J, Krause M, O'Hagan C, De Vito G, Boreham C, Murphy C, Newsholme P & Colleran G. 2012 Divergence of intracellular and extracellular HSP72 in type 2 diabetes: does fat matter? Cell Stress & Chaperones 17 293-302.
31. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M & Santoro MG. 2000 Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkB kinase. Nature 403 103-108.
32. Ruderman NB, Keller C, Richard AM, Saha AK, Luo Z, Xiang X, Giralt M, Ritov VB, Menshikova EV, Kelley DE et al. 2006 Interleukin-6 regulation of AMP-activated protein kinase, Potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 55 (Suppl 2) S48-S54.
33. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW & Mooney RA. 2003 Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. Journal of Biological Chemistry 278 13740-13746.
34. Smukler SR, Tang L, Wheeler MB & Salapatek AM. 2002 Exogenous nitric oxide and endogenous glucose-stimulated β-cell nitric oxide augment insulin release. Diabetes 51 3450-3460.
35. Spinas GA. 1999 The dual role of nitric oxide in islet β-cells. News in Physiological Sciences 14 49-54.
36. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H & Pfeiffer AF. 2003 Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52 812-817.
37. Steinberg GR & Jorgensen SB. 2007 The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Reviews in Medicinal Chemistry 7 519-526.
38. Sunouchi T, Suzuki K, Nakayama K & Ishikawa T. 2008 Dual effect of nitric oxide on ATP-sensitive KC channels in rat pancreatic b cells. Pflügers Archiv 456 573-579.
39. Suzuki T, Imai J, Yamada T, Ishigaki Y, Kaneko K, Uno K, Hasegawa Y, Ishihara H, Oka Y & Katagiri H. 2011 Interleukin-6 enhances glucosestimulated insulin secretion from pancreatic β-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 60 537-547.
40. Zhang F, Dey D, Branstrom R, Forsberg L, Lu M, Zhang Q, Sjoholm A & Sjoholm A. 2009 BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2C, and enhances glucose-stimulated insulin secretion in a PI3Kdependent manner. American Journal of Physiology. Cell Physiology 296 C346-C354.
41. Zou MH, Hou XY, Shi CM, Kirkpatick S, Liu F, Goldman MH& Cohen RA. 2003 Activation of 50-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells. Role of peroxynitrite. Journal of Biological Chemistry 278 34003-34010.